...
首页> 外文期刊>Lancet Neurology >Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study
【24h】

Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study

机译:血清GFAP和UCH-L1用于预测头部CT的颅内损伤(ALERT-TBI):多方面观察研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background More than 50 million people worldwide sustain a traumatic brain injury (TBI) annually. Detection of intracranial injuries relies on head CT, which is overused and resource intensive. Blood-based brain biomarkers hold the potential to predict absence of intracranial injury and thus reduce unnecessary head CT scanning. We sought to validate a test combining ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP), at predetermined cutoff values, to predict traumatic intracranial injuries on head CT scan acutely after TBI.
机译:背景,全球5000多万人每年维持创伤性脑损伤(TBI)。 颅内损伤的检测依赖于头CT,这是过度使用和资源密集的。 基于血液的脑生物标志物占据了预测颅内损伤的可能性,从而减少了不必要的头CT扫描。 我们试图在预定的截止值下验证泛素C末端水解酶-L1(UCH-L1)和胶质纤维酸性蛋白(GFAP)的测试,以预先在TBI后急性扫描的引起创伤性颅内损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号